MCID: END024
MIFTS: 13

Endometrial Transitional Cell Carcinoma

Categories: Cancer diseases, Reproductive diseases

Aliases & Classifications for Endometrial Transitional Cell Carcinoma

MalaCards integrated aliases for Endometrial Transitional Cell Carcinoma:

Name: Endometrial Transitional Cell Carcinoma 12 15 74

Classifications:



External Ids:

Disease Ontology 12 DOID:4005
NCIt 51 C40154
UMLS 74 C1516864

Summaries for Endometrial Transitional Cell Carcinoma

Disease Ontology : 12 An endometrial carcinoma that derives from transitional epithelial cells.

MalaCards based summary : Endometrial Transitional Cell Carcinoma is related to transitional cell carcinoma of the corpus uteri. An important gene associated with Endometrial Transitional Cell Carcinoma is CDKN2A (Cyclin Dependent Kinase Inhibitor 2A). The drugs Nintedanib and Ipilimumab have been mentioned in the context of this disorder. Affiliated tissues include endothelial.

Related Diseases for Endometrial Transitional Cell Carcinoma

Diseases related to Endometrial Transitional Cell Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 transitional cell carcinoma of the corpus uteri 11.6

Symptoms & Phenotypes for Endometrial Transitional Cell Carcinoma

Drugs & Therapeutics for Endometrial Transitional Cell Carcinoma

Drugs for Endometrial Transitional Cell Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 23)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Nintedanib Approved Phase 2 656247-17-5 56843413
2
Ipilimumab Approved Phase 2 477202-00-9
3
nivolumab Approved Phase 2 946414-94-4
4
Tyrosine Approved, Investigational, Nutraceutical Phase 2 60-18-4 6057
5 Immunologic Factors Phase 2,Phase 1
6 Immunoglobulins Phase 2,Phase 1
7 Immunoglobulin Fc Fragments Phase 2
8 Antibodies Phase 2,Phase 1
9 Mitogens Phase 2,Phase 1
10 Antineoplastic Agents, Immunological Phase 2,Phase 1
11 Antibodies, Monoclonal Phase 2,Phase 1
12
Dasatinib Approved, Investigational Phase 1 302962-49-8 3062316
13
Carboplatin Approved Phase 1 41575-94-4 10339178 38904 498142
14
Paclitaxel Approved, Vet_approved Phase 1 33069-62-4 36314
15
Bevacizumab Approved, Investigational Phase 1 216974-75-3
16 Protein Kinase Inhibitors Phase 1
17 Antineoplastic Agents, Phytogenic Phase 1
18 Antimitotic Agents Phase 1
19 Albumin-Bound Paclitaxel Phase 1
20 Angiogenesis Modulating Agents Phase 1
21 Immunoglobulin G Phase 1
22 Endothelial Growth Factors Phase 1
23 Angiogenesis Inhibitors Phase 1

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer Completed NCT01642082 Phase 2
2 Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer Completed NCT01225887 Phase 2 Nintedanib
3 Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer Completed NCT00888173 Phase 2 Brivanib Alaninate
4 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Recruiting NCT02834013 Phase 2
5 Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer Completed NCT01440998 Phase 1 Carboplatin;Dasatinib;Paclitaxel
6 Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery or Gynecological Cancers Suspended NCT02020707 Phase 1 Paclitaxel Albumin-Stabilized Nanoparticle Formulation

Search NIH Clinical Center for Endometrial Transitional Cell Carcinoma

Genetic Tests for Endometrial Transitional Cell Carcinoma

Anatomical Context for Endometrial Transitional Cell Carcinoma

MalaCards organs/tissues related to Endometrial Transitional Cell Carcinoma:

42
Endothelial

Publications for Endometrial Transitional Cell Carcinoma

Variations for Endometrial Transitional Cell Carcinoma

Expression for Endometrial Transitional Cell Carcinoma

Search GEO for disease gene expression data for Endometrial Transitional Cell Carcinoma.

Pathways for Endometrial Transitional Cell Carcinoma

GO Terms for Endometrial Transitional Cell Carcinoma

Sources for Endometrial Transitional Cell Carcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....